Publication | Open Access

The immune-metabolic-prognostic index and clinical outcomes in patients with non-small cell lung carcinoma under checkpoint inhibitors

Cancer ImmunosurveillanceCheckpoint InhibitorsImmune-metabolic-prognostic IndexMedicineImmunologyPathologyBronchial NeoplasmImmune Checkpoint InhibitorClinical OutcomesCancer TreatmentOncologyTumor MicroenvironmentLung Cancer